Health Condition 1: K040- Pulpitis
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Asian healthy (ASA I) subjects of either gender between 18 and 50 years of age. 2. Patients diagnosed with symptomatic irreversible pulpitis in mandibular molars
Exclusion criteria
Exclusion criteria: Patients on medication with analgesics for dental pain within last 24 hours Patients allergic to lignocaine and adrenaline Patients allergic to ibuprofen Patients with peptic ulcers, or any underlying Gastrointestinal tract conditions/diseases. Patients with renal disorders. Patients with poor oral hygiene and periodontal disease Patients with chronic pain syndromes and neuropathic disorders Patients with thrombocytopenia and related conditions Patients with autoimmune disease Pregnant patients
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To investigate the effectiveness of precooled lignocaine in combination with ibuprofen as pre-anaesthetic medication on success rate of pulpal anaesthesia in mandibular molars with symptomatic irreversible pulpitis. Timepoint: pain recorded during endodontic treatment approximately lasting for 45mins to 1 hour | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. To evaluate the success rate of pulpal anaesthesia with precooled anaesthesia in mandibular molars with symptomatic irreversible pulpitis 2. To evaluate the success rate of pulpal anaesthesia with Pre-anaesthetic medication in combination with precooled anaesthesia in mandibular molars with symptomatic irreversible pulpitis. 3. To compare the above Timepoint: pain recorded during endodontic treatment approximately lasting for 45mins to 1 hour | — |
Countries
India